Oculis (OCS) Stock Forecast, Price Target & Predictions
OCS Stock Forecast
Oculis stock forecast is as follows: an average price target of $33.50 (represents a 101.44% upside from OCS’s last price of $16.63) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
OCS Price Target
The average price target for Oculis (OCS) is $33.50 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $37.00 to $30.00. This represents a potential 101.44% upside from OCS's last price of $16.63.
OCS Analyst Ratings
According to 2 Wall Street analysts, Oculis's rating consensus is 'Buy'. The analyst rating breakdown for OCS stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Oculis Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jun 11, 2024 | Yi Chen | H.C. Wainwright | $30.00 | $12.00 | 150.00% | 80.40% |
| Jun 10, 2024 | Colleen Kusy | Robert W. Baird | $37.00 | $12.00 | 208.33% | 122.49% |
The latest Oculis stock forecast, released on Jun 11, 2024 by Yi Chen from H.C. Wainwright, set a price target of $30.00, which represents a 150.00% increase from the stock price at the time of the forecast ($12.00), and a 80.40% increase from OCS last price ($16.63).
Oculis Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $33.50 |
| Last Closing Price | $16.63 | $16.63 | $16.63 |
| Upside/Downside | -100.00% | -100.00% | 101.44% |
In the current month, the average price target of Oculis stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Oculis's last price of $16.63. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 24, 2024 | Sandler O'Neill | Underperform | Underperform | Hold |
| Aug 28, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Aug 21, 2024 | Sandler O'Neill | Underperform | Underperform | Hold |
| Jul 15, 2024 | Sandler O'Neill | Underperform | Underperform | Hold |
| Jun 21, 2024 | Sandler O'Neill | Underperform | Underperform | Hold |
| Jun 11, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Jun 11, 2024 | Bank of America Securities | Buy | Buy | Hold |
Oculis's last stock rating was published by Sandler O'Neill on Sep 24, 2024. The company gave OCS a "Underperform" rating, the same as its previous rate.
Oculis Financial Forecast
Oculis Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $165.84K | $165.84K | $165.84K | $186.57K | $239.73K | $237.02K | $244.67K | $261.04K | $240.26K | $110.86K | $175.07K |
| High Forecast | $165.84K | $165.84K | $165.84K | $186.57K | $239.73K | $279.35K | $244.67K | $261.04K | $291.75K | $110.86K | $175.07K |
| Low Forecast | $165.84K | $165.84K | $165.84K | $186.57K | $239.73K | $211.63K | $244.67K | $261.04K | $214.52K | $110.86K | $175.07K |
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 5 | 2 | 2 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Oculis's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. OCS's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Oculis EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 5 | 2 | 2 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $-165.84K | $-165.84K | $-165.84K | $-186.57K | $-239.73K | $-237.02K | $-244.67K | $-261.04K | $-240.26K | $-110.86K | $-175.07K |
| High Forecast | $-165.84K | $-165.84K | $-165.84K | $-186.57K | $-239.73K | $-211.63K | $-244.67K | $-261.04K | $-214.52K | $-110.86K | $-175.07K |
| Low Forecast | $-165.84K | $-165.84K | $-165.84K | $-186.57K | $-239.73K | $-279.35K | $-244.67K | $-261.04K | $-291.75K | $-110.86K | $-175.07K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - |
undefined analysts predict OCS's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Oculis's previous annual EBITDA (undefined) of $NaN.
Oculis Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 5 | 2 | 2 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $-16.35M | $-16.35M | $-16.35M | $-16.35M | $-18.66M | $-18.93M | $-16.87M | $-14.88M | $-16.82M | $-13.28M | $-10.55M |
| High Forecast | $-16.35M | $-16.35M | $-16.35M | $-16.35M | $-18.66M | $-17.47M | $-16.87M | $-14.88M | $-16.42M | $-13.28M | $-10.55M |
| Low Forecast | $-16.35M | $-16.35M | $-16.35M | $-16.35M | $-18.66M | $-21.48M | $-16.87M | $-14.88M | $-17.62M | $-13.28M | $-10.55M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Oculis's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. OCS's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Oculis SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 5 | 2 | 2 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $1.45M | $1.45M | $1.45M | $1.63M | $2.10M | $2.07M | $2.14M | $2.28M | $2.10M | $970.17K | $1.53M |
| High Forecast | $1.45M | $1.45M | $1.45M | $1.63M | $2.10M | $2.44M | $2.14M | $2.28M | $2.55M | $970.17K | $1.53M |
| Low Forecast | $1.45M | $1.45M | $1.45M | $1.63M | $2.10M | $1.85M | $2.14M | $2.28M | $1.88M | $970.17K | $1.53M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Oculis's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to OCS last annual SG&A of $NaN (undefined).
Oculis EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 5 | 2 | 2 |
| EPS | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $-0.40 | $-0.40 | $-0.40 | $-0.40 | $-0.46 | $-0.47 | $-0.42 | $-0.37 | $-0.41 | $-0.33 | $-0.26 |
| High Forecast | $-0.40 | $-0.40 | $-0.40 | $-0.40 | $-0.46 | $-0.43 | $-0.42 | $-0.37 | $-0.40 | $-0.33 | $-0.26 |
| Low Forecast | $-0.40 | $-0.40 | $-0.40 | $-0.40 | $-0.46 | $-0.53 | $-0.42 | $-0.37 | $-0.43 | $-0.33 | $-0.26 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - |
According to undefined Wall Street analysts, Oculis's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to OCS previous annual EPS of $NaN (undefined).
OCS Forecast FAQ
Is Oculis a good buy?
Yes, according to 2 Wall Street analysts, Oculis (OCS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of OCS's total ratings.
What is OCS's price target?
Oculis (OCS) average price target is $33.5 with a range of $30 to $37, implying a 101.44% from its last price of $16.63. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Oculis stock go up soon?
According to Wall Street analysts' prediction for OCS stock, the company can go up by 101.44% (from the last price of $16.63 to the average price target of $33.5), up by 122.49% based on the highest stock price target, and up by 80.40% based on the lowest stock price target.
Can Oculis stock reach $20?
OCS's average twelve months analyst stock price target of $33.5 supports the claim that Oculis can reach $20 in the near future.
What are Oculis's analysts' financial forecasts?
Oculis's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $982.47K (high $1.02M, low $957.08K), average EBITDA is $-982K (high $-957K, low $-1.025M), average net income is $-69.342M (high $-67.886M, low $-71.89M), average SG&A $8.6M (high $8.97M, low $8.38M), and average EPS is $-1.711 (high $-1.675, low $-1.774). OCS's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $684.1K (high $684.1K, low $684.1K), average EBITDA is $-684K (high $-684K, low $-684K), average net income is $-65.409M (high $-65.409M, low $-65.409M), average SG&A $5.99M (high $5.99M, low $5.99M), and average EPS is $-1.614 (high $-1.614, low $-1.614).